Willner & Heller LLC Makes New $642,000 Investment in Axon Enterprise, Inc $AXON

Willner & Heller LLC purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 1,131 shares of the biotechnology company’s stock, valued at approximately $642,000.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after acquiring an additional 376,904 shares during the period. Jennison Associates LLC increased its position in Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock valued at $677,412,000 after purchasing an additional 330,213 shares during the period. Norges Bank bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at about $637,806,000. Northern Trust Corp raised its holdings in shares of Axon Enterprise by 1.6% in the 3rd quarter. Northern Trust Corp now owns 743,926 shares of the biotechnology company’s stock valued at $533,871,000 after purchasing an additional 11,726 shares in the last quarter. Finally, 1832 Asset Management L.P. lifted its position in shares of Axon Enterprise by 129.2% in the 2nd quarter. 1832 Asset Management L.P. now owns 536,420 shares of the biotechnology company’s stock worth $444,124,000 after purchasing an additional 302,420 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.8%

Shares of Axon Enterprise stock opened at $460.15 on Thursday. The firm’s 50 day moving average price is $509.91 and its 200-day moving average price is $595.01. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91. The company has a market cap of $37.00 billion, a P/E ratio of 302.73, a PEG ratio of 9.75 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.08 earnings per share. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. UBS Group cut their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a report on Wednesday, February 25th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Citigroup reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Robert W. Baird set a $800.00 price target on Axon Enterprise in a report on Wednesday, February 25th. Finally, Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $762.93.

Insider Buying and Selling at Axon Enterprise

In other news, Director Erika Nardini sold 198 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total transaction of $100,302.84. Following the transaction, the director directly owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This represents a 9.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the sale, the chief accounting officer owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. This represents a 10.92% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 23,855 shares of company stock valued at $13,299,928. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.